A Novel Monoclonal Antibody Specific to Non-small Cell Lung Cancer Inhibits Tumor Cell Growth and Bl

来源 :中华医学第九次全国检验医学学术会议暨中国医院协会临床检验管理专业委员会第六届全国临床检验实验室管理学术会议 | 被引量 : 0次 | 上传用户:yst598
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
@@ We aim to prepare and characterize a monoclonal antibody(McAb)against human non-small cell lung cancer(NSCLC),and to further investigate the inhibitory effect ofthis McAb on the proliferation of lung adenocarcinoma eell lineSPC.A1 in.vitro and in-vivo.BALB/c mice were immunized with human lung adenocarcinoma cells and the spleen cells of the immunized mice were conventionally fused with SP2/0 myeloma cells.The resulting positive clone,which produced McAb against SPC-A1.was obtained by means of indirect cell ELISA screemng.and the specificity of the McAb was indicated through ELISA and an indirect immunofluorescence assay.The relative molecular mass(Mr)of the antigen recognized by the McAb was measured by Westem blot and immunohistochemical analysis was performed to detect the tissue specificity of the McAb.SPC-A1 cells were plated on a soft agar matrix and treated with various concentrations of McAb;the colony formation efficiency and the inhibition ratio of colonies were then calculated.The xenograft was established upon subcutaneous injection of SPC-A1 cells and McAb,administered intraperitoneally at three difierent doses.The mice were monitored for tumor size.
其他文献
针对国际上在上世纪七十年代研制出的用于临床实验室常规检铡糖化血红蛋白(HbAlc)的产品出现的非特异性问题,本文主要对1993年美国临床化学协会建立的美国国家糖化血红蛋白标准化计划(NGSP)和1995年国际临床化学协会((IFCC)建立的糖化血红蛋白标准化工作组对提高HbAlc检测的方法进行了介绍,并且我国在2010年3月也启动了《中国糖化血红蛋白教育计划》项目,对每个阶段的详细工作计划和主要内
文章对血尿能否被肉眼发现分类、原因、鉴别要点作了详细论述,并对血尿的病因分类及鉴别要点作了详细论述,随后对白色混浊尿和蛋白尿检测的要点做了阐述。
@@ 25-hydroxyvitamin D(D3/D2)is frequently tested in clinicaflaboratories due to its importance in the management of patients with bone disease and the association between 25-hydroxyvitamin D(25(OH)D)
会议
生化分析前的质量控制是全面质量控制中最难控制的环节,是获得准确、可靠检验结果的必要前提条件。重视和加强检验前质量控制,是进一步提高检验质量的重要组成部分。生化分析前质量控制的流程主要有:检验申请、患者准备、样本采集、标本运输等,而影响其检验结果的因素包括不可变的生物因素和可变的生物因素;我们通过分析质量控制前的关键环节及措施,来减少分析前存在的问题。
针对我国血脂异常人群的“叠加风险”情况,国内外血脂异常防治指南部给出了血脂异常危险分层、个体化血脂目标值和调脂治疗的具体建议,但近年的研究资料提示,非HDL-C, apoB(尤其是apoB)用作调脂治疗靶标的呼声越来越高,特别是对于剩留血管风险防治意义显著。文章介绍了治疗LDL-C、非HDL-C和apoB的重要性、指标以及检测方法做了介绍,最后结论为:免疫浊度法检测apoS己基本实现标准化,有较高
@@ To investigate the serum blirubin levels inSLE patients and explore independent impactfactors of the varied serum bilirubin levels and theassociations with some clinical and laboratorycharacteristi
会议
@@ To systematically assess whether theseB,lm microRNAs(miRNAs)profiling Call predictgestational diabetes mellitus(GDM)in advante ofthe measurement of blood glucose.Methods We used systematically TaqM
会议
@@ To evaluate fluorescence characteristics and clinical significance of anti.SSA and SSB antibodies and to explore whether identification of these antibodies was necessary in sera for ANA testing.Of
会议
目的:优化并建立功能性CCP/AST细胞分泌工FN-γ与IL-4的ELIspot检测方法,同时以四聚体流式细胞术研究CCP/AST细胞在RA中的阳性发生频数,探讨CCP/AST细胞在RA疾病发生、发展中的作用与临床意义。  方法:以CCP抗原肤为特异性刺激物,FLAG肤为对照,用ELIspot检测64例RA患者、64例非RA患者及30名健康人PBMC分泌IFN-γ、IL-4的阳性SFCs频数与比值
目的:了解肾移植术后稳定期受者、感染期受者外周血中性粒细胞粘附分子CD11b和CD18髓过氧化物酶(MPO)的变化和意义。  方法:1 临床资料 全部肾移植受者均为我院肾移植科门诊和住院病人共30例,均为首次移植。受者给与常规免疫抑制剂治疗(激素+环抱素或普乐可复+骁悉或他克莫司)。根据是否发生感染分为感染组和稳定组。感染组:10例,男7例,女3例,平均年龄32岁。稳定组:20例,男13例,女7例